PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
Visit https://www.peervoice.com/GHN860 to view the entire programme with slides. After completing “Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022”, participants will be able to: Describe emerging data for targeted therapeutic strategies for management of patients with advanced non–small-cell lung cancer (NSCLC) and actionable mutations; Evaluate how these data add to current knowledge of the management of biomarker-positive advanced NSCLC; and Discuss the clinical implications of these data in the context of current advanced NSCLC treatment paradigms.